Minitablets: New modality to deliver medicines to preschool-aged children

Pediatrics

Volumn 123, Issue 2, 2009, Pages

  Thomson, Sarah A ^a,b   Tuleu, Catherine ^a,b   Wong, Ian C K ^a,b   Keady, Simon ^a,c   Pitt, Kendal G ^d   Sutcliffe, Alastair G ^c  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Minitablets; Oral dosage form

Indexed keywords

PLACEBO;

ARTICLE; CHILD; CHILD HEALTH CARE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINITABLET; PATIENT PARTICIPATION; PRESCHOOL CHILD; PRIORITY JOURNAL; TABLET; TABLET FORMULATION; TABLET PROPERTY; UNITED KINGDOM; EVALUATION; PATIENT SATISFACTION;

CHILD; CHILD, PRESCHOOL; HUMANS; PATIENT SATISFACTION; TABLETS;

EID: 61549095823     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-2059     Document Type: Article

References (19)

1. Sutcliffe AG. Prescribing medicines for children. BMJ. 1999; 319(7202):70-71
2. Wong ICK, Sweis D, Cope J, Florence A. Paediatric medicines research in the UK: how to move forward? Drug Saf. 2003; 26(8):529-537
3. Schirm E, Tobi H, de Vries TW, Choonara I, De Jong-van den Berg L. Lack of appropriate formulations of medicines for children in the community. Acta Paediatr. 2003;92(12):1486-1489
4. Committee for Medicinal Products for Human Use (CHMP). Reflection Paper: Formulation of Choice for the Paediatric Population. EMEA/CHMP/PEG/194810/ 2005[online]. Available at: www.emea.europa.eu/pdfs/human/paediatrics/ 19481005en. pdf. Accesssed December 11, 2008
5. Lamprill J. Paediatric trials: balancing profit and ethical safeguards. CRfocus. 2005;16(4):13-18
6. Autret-Leca E, Bensouda-Grimaldi L, Le Guellec C, Jonville- Bera AP. Prescriptions and children [in French]. Arch Pediatr. 2006;13(2):181-185
7. Turner S, Longworth A, Nunn AJ, Choonara I. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ. 1998;316(7128):343-345
8. Nunn AJ. Making medicines that children can take. Arch Dis Child. 2003;88(5):369-371
9. Kölch M, Schnoor K, Fegert JM. The EU-regulation on medicinal products for paediatric use: impacts on child and adolescent psychiatry and clinical research with minors. Eur Child Adolesc Psychiatry. 2007;16(4):229-235
10. Tomlin S. Understanding how to select appropriate liquid medicines for children will ensure they receive the best-available product for their needs. Pharm Pract. September 2007:211-213
11. Breitkreutz J, Boos J. Paediatric and geriatric drug delivery. Expert Opin Drug Deliv. 2007;4(1):37-45
12. American Academy of Pediatrics, Committee on Drugs. "Inactive" ingredients in pharmaceutical products: update (subject review). Pediatrics. 1997;99(2):268-278
13. Nunn T, Williams J. Formulation of medicines for children. Br J Clin Pharmacol. 2005;59(6):674-676
14. Ruark JL, McCollough GH, Peters RL, Moore CA. Bolus consistency and swallowing in children and adults. Dysphagia. 2002;17(1):24-33
15. Yeung VW, Wong ICK. When do children convert from liquid antiretroviral to solid formulations? Pharm World Sci. 2005; 27(5):399-402
16. Czyzewski DI, Runyan D, Lopez MA, Calles NR. Teaching and maintaining pill swallowing in HIV-infected children. AIDS Read. 2000;10(2):88-94
17. Babbitt RL, Parrish JM, Brierley PE, Kohr MA. Teaching de- velopmentally disabled children with chronic illness to swallow prescribed capsules. J Dev Behav Pediatr. 1991;12(4): 229-235
18. Garvie PA, Lensing S, Rai SN. Efficacy of a pill-swallowing training intervention to improve antiretroviral medication adherence in pediatric patients with HIV/AIDS. Pediatrics. 2007;119(4). Available at: www.pediatrics.org/cgi/content/full/119/4/e893
19. Lennartz P, Mielck JB. Minitabletting: improving the com- pactability of paracetamol powder mixtures. Int J Pharm. 1998; 173(1-2):75-85